Peptide Atlas · Mineral
Iron dextran
In 688,183 Medicare patients given intravenous iron, the risk of anaphylaxis at first exposure was 68 per 100,000 for iron dextran against 24 per 100,000 for the non-dextran products combined.
- established
- provisional
- 2 citations
- 0 discussions
- 0 followers
- Cosmofer
- Dexferrum
- INFeD
- high/low molecular weight iron dextran
- iron(III)-dextran complex
What the evidence says
six tiers, never blendedestablished — replicated in humans, or settled by a regulator
every claim resolves to its source
All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.
Negative findings
failure is informationNobody has filed a failure yet. Failures are information; this list is waiting for an honest one.